Nektar Therapeutics reported $18.65M in Gross Profit on Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Agios Pharmaceuticals AGIO:US USD 3M 2.15M
ALKERMES ALKS:US USD 201.73M 16.13M
Amgen AMGN:US USD 5.09B 28M
Astrazeneca AZN:US USD 8.86B 3M
Baxter International BAX:US USD 1.15B 310M
Biocryst Pharmaceuticals BCRX:US USD 72.21M 6.93M
Biogen BIIB:US USD 2.04B 66.1M
Bluebird Bio BLUE:US USD 71K 297K
Bristol Myers Squibb BMY:US USD 8.89B 21M
Cara Therapeutics CARA:US USD 7.76M 15.24M
Dr.Reddys Laboratories DRRD:IN INR 47.88B 3.04B
Eisai 4523:JP JPY 129.23B 7.63B
Eli Lilly And LLY:US USD 5.75B 391.2M
Esperion Therapeutics ESPR:US USD 12.47M 2.81M
Exelixis EXEL:US USD 396.43M 9.51M
Gilead Sciences GILD:US USD 5.99B 346M
GlaxoSmithKline GSK:LN GBP 5.2B 244M
Halozyme Therapeutics HALO:US USD 161.66M 43.24M
IONIS PHARMACEUT IONS:US USD 158.25M 29.21M
Karyopharm Therapeutics KPTI:US USD 35.16M 3.58M
MacroGenics MGNX:US USD 38.59M 14.99M
Merk MRK:US USD 10.47B 610M
Nektar Therapeutics NKTR:US USD 18.65M 2.18M
Neurocrine Biosciences NBIX:US USD 381.8M 8.4M
Novartis NOVN:VX USD 9.18B 151M
Pfizer PFE:US USD 14.47B 2.08B
Roche Holding ROG:VX 22.73B 924M
Sarepta Therapeutics SRPT:US USD 190.32M 5.38M
Seattle Genetics SGEN:US USD 402.18M 10.78M
Takeda 4502:JP JPY 760.58B 63.72B
Teva Pharmaceutical TEVA:IT USD 1.71B 118M
YTE INCY:US USD 774.02M 92.14M